The Asia Pacific Iliac Stent Market would witness market growth of 6.8% CAGR during the forecast period (2023-2030).
The China market dominated the Asia Pacific Iliac Stent Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $90.9 million by 2030. The Japan market is registering a CAGR of 6.2% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 7.6% during (2023 - 2030).
Favourable reimbursement rates, coverage policies, and coding guidelines incentivize using these and support market growth by ensuring adequate reimbursement for stent placement procedures and associated healthcare services. Additionally, cost-effectiveness analyses, budget impact assessments, and health technology assessments (HTAs) inform decision-making regarding allocating healthcare resources and adopting new medical technologies, influencing adoption trends and market penetration of its interventions.
Patient preferences, values, and treatment goals play a significant role in adopting such procedures, influencing treatment decisions, adherence to therapy, and satisfaction with care. Factors such as treatment efficacy, safety, invasiveness, recovery time, and quality of life considerations influence patient preferences for iliac stenting versus alternative treatment options, such as medical management, exercise therapy, or surgical revascularization.
The expansion of the medical device industry in India may lead to technology transfer agreements and collaborations with international manufacturers of medical devices, including iliac stents. According to the India Brand Equity Foundation, the Indian medical equipment industry will be valued at $50 billion by 2030. This industry has attracted substantial investments over time. In FY20, foreign investments in medical devices increased by 98% year-over-year to Rs. 2,196 crore (US$301.01 million). Therefore, the market’s growth is driven by the region’s aging population and the expansion of the medical device industry.
Based on Artery Lesions, the market is segmented into Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions. Based on End-use, the market is segmented into Hospitals, Outpatient Facilities, and Others. Based on Type, the market is segmented into Self-expandable Stents, Balloon-expandable Stents, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The China market dominated the Asia Pacific Iliac Stent Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $90.9 million by 2030. The Japan market is registering a CAGR of 6.2% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 7.6% during (2023 - 2030).
Favourable reimbursement rates, coverage policies, and coding guidelines incentivize using these and support market growth by ensuring adequate reimbursement for stent placement procedures and associated healthcare services. Additionally, cost-effectiveness analyses, budget impact assessments, and health technology assessments (HTAs) inform decision-making regarding allocating healthcare resources and adopting new medical technologies, influencing adoption trends and market penetration of its interventions.
Patient preferences, values, and treatment goals play a significant role in adopting such procedures, influencing treatment decisions, adherence to therapy, and satisfaction with care. Factors such as treatment efficacy, safety, invasiveness, recovery time, and quality of life considerations influence patient preferences for iliac stenting versus alternative treatment options, such as medical management, exercise therapy, or surgical revascularization.
The expansion of the medical device industry in India may lead to technology transfer agreements and collaborations with international manufacturers of medical devices, including iliac stents. According to the India Brand Equity Foundation, the Indian medical equipment industry will be valued at $50 billion by 2030. This industry has attracted substantial investments over time. In FY20, foreign investments in medical devices increased by 98% year-over-year to Rs. 2,196 crore (US$301.01 million). Therefore, the market’s growth is driven by the region’s aging population and the expansion of the medical device industry.
Based on Artery Lesions, the market is segmented into Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions. Based on End-use, the market is segmented into Hospitals, Outpatient Facilities, and Others. Based on Type, the market is segmented into Self-expandable Stents, Balloon-expandable Stents, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Becton, Dickinson and Company
- Abbott Laboratories
- Boston Scientific Corporation
- W.L. Gore & Associates, Inc.
- Medtronic PLC
- Cook Medical, Inc.(Cook Group)
- Terumo Corporation
- iVascular S.L.U.
- Getinge AB
- Biotronik SE & Co. KG
Market Report Segmentation
By Artery Lesions- Common Iliac Artery Lesions
- Severe Calcified Lesions
- Complete Obstructive Lesions
- Hospitals
- Outpatient Facilities
- Others
- Self-expandable Stents
- Balloon-expandable Stents
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Iliac Stent Market by Artery Lesions
Chapter 5. Asia Pacific Iliac Stent Market by End-use
Chapter 6. Asia Pacific Iliac Stent Market by Type
Chapter 7. Asia Pacific Iliac Stent Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Becton, Dickinson and Company
- Abbott Laboratories
- Boston Scientific Corporation
- W. L. Gore & Associates, Inc.
- Medtronic PLC
- Cook Medical, Inc.(Cook Group)
- Terumo Corporation
- iVascular S.L.U.
- Getinge AB
- Biotronik SE & Co. KG
Methodology
LOADING...
